Kallen Schwark is a graduate student and MD/PhD fellow at the University of Michigan, working in the lab of Dr. Carl Koschmann. He is studying the optimization of PDGFRA inhibition therapy in pediatric high-grade glioma. Previously, he graduated from the University of Michigan in 2018 with a degree in Biomedical Engineering. He is interested in cancer genetics, metabolism, and developmental therapeutics.